+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioresorbable Polymers Market - Global Forecast to 2030- Product Image
Bioresorbable Polymers Market - Global Forecast to 2030- Product Image
Sale

Bioresorbable Polymers Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010901
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bioresorbable Polymers Market grew from USD 998.48 million in 2024 to USD 1.10 billion in 2025. It is expected to continue growing at a CAGR of 10.51%, reaching USD 1.81 billion by 2030.

Bioresorbable polymers have emerged as a pivotal class of materials, offering transformative potential across biomedical, pharmaceutical, and industrial applications. These materials degrade safely within the body or environment, eliminating the need for surgical removal and reducing long-term complications. Recent advances in polymer chemistry and manufacturing techniques have accelerated adoption in tissue engineering scaffolds, drug delivery vehicles, and wound‐healing devices. Moreover, evolving regulatory frameworks and heightened demand for minimally invasive treatments are bolstering research investments and commercialization efforts. As stakeholders navigate a rapidly shifting marketplace, a clear understanding of technological breakthroughs and supply chain dynamics becomes essential. This executive summary provides a concise yet comprehensive overview of the driving forces, market segmentation, regional dynamics, key players, and strategic recommendations poised to shape the future of the bioresorbable polymers landscape. By examining these dimensions in concert, decision-makers can align R&D priorities, optimize manufacturing processes, and leverage emerging opportunities, ensuring sustained competitiveness and superior patient outcomes.

Transformative Shifts Reshaping the Bioresorbable Polymers Landscape

The landscape of bioresorbable polymers is undergoing transformative shifts driven by converging technological, regulatory, and market forces. Material scientists are now engineering next-generation polyhydroxyalkanoates and polyanhydrides with tunable degradation kinetics, enabling bespoke applications from controlled-release therapeutics to bioresorbable stents. Simultaneously, manufacturing breakthroughs in extrusion, injection molding, and blow molding are driving cost efficiencies and scalability. Regulatory bodies worldwide have begun streamlining approval pathways, reflecting growing confidence in polymer safety profiles and clinical performance data.

Market dynamics are also shifting: a surge in collaborative ventures between pharmaceutical firms and polymer innovators is accelerating the translation of lab-scale concepts into commercial products. Advances in micro- and nano-fabrication methods allow for precisely engineered drug-loaded particles, while innovations in scaffold design support more effective tissue regeneration. Moreover, the growing emphasis on sustainability has prompted the development of biopolymers derived from renewable feedstocks, integrating environmental considerations into product lifecycles.

As a result of these tectonic shifts, industry participants must adopt agile R&D strategies, forge strategic alliances, and remain vigilant to regulatory evolutions. The stage is set for a new era of high-performance bioresorbable solutions that will redefine patient care and industrial utility alike.

Assessing the Cumulative Impact of U.S. Tariffs in 2025

The imposition of United States tariffs in early 2025 has rippled through the bioresorbable polymers supply chain, influencing raw material sourcing, manufacturing costs, and end-product pricing. Imported polymers such as polylactic acid and polycaprolactone now face elevated duties, prompting domestic producers to expand capacity and diversify supplier relationships. This pivot toward regionalized supply chains enhances resilience but may also introduce margin pressures as logistics and production expenses rise.

In response, several contract manufacturers have accelerated toshore initiatives, upgrading extrusion and blow molding lines to process bioresorbable grades locally. Research organizations are likewise exploring feedstock alternatives, including bio-based monomers that can be sourced domestically to mitigate tariff exposure. Meanwhile, end-users such as pharmaceutical companies and medical device OEMs are reassessing long-term agreements to negotiate more favorable terms or to seek tariff-exempt status under specific trade provisions.

Despite these challenges, the market’s growth trajectory remains intact, driven by clinical demand and technological innovation. Successfully navigating the tariff landscape will require stakeholders to optimize production footprints, leverage free trade zones, and engage proactively with customs authorities. Through these measures, the industry can absorb cost shocks while maintaining supply stability and competitive pricing.

Key Market Segmentation Insights Driving Growth and Innovation

A nuanced understanding of market segmentation is crucial for tailoring product development and go-to-market approaches. Within the product domain, fibers and films continue to dominate high-volume applications, while micro-particles and nanomaterials enable precision drug delivery and tissue engineering. Form factors span liquid formulations for injectable therapies, powders suitable for additive manufacturing, and solid constructs employed in implantable devices. From the manufacturing standpoint, extrusion techniques support continuous production of films and fibers, injection molding yields complex implant geometries, and blow molding offers cost-effective production of hollow scaffolds.

Material type segmentation illuminates the strengths of each polymer class: polyanhydrides excel in surface-erosion drug delivery, whereas polyglycolic acid and polylactic acid provide robust mechanical properties and established safety profiles. Polycaprolactone offers extended degradation timelines for long-term implants, while polyhydroxyalkanoates deliver biodegradability from renewable sources. Application segmentation underscores diverse use cases, from controlled-release formulations and target-specific vehicles in drug delivery systems to cardiovascular stents and orthopedic implants in medical devices. Tissue engineering efforts leverage both scaffold designs and stem cell scaffolding to enhance regenerative outcomes. In the wound care arena, adhesive solutions and advanced bandaging materials accelerate healing and reduce infection risk. End-user segmentation reflects a mature ecosystem comprising biotechnology firms, hospitals and clinics, pharmaceutical companies, and research institutes, each driving unique demand profiles.

Regional Dynamics Influencing Bioresorbable Polymer Adoption

Regional dynamics exert significant influence over production capabilities, regulatory environments, and commercialization strategies. In the Americas, the United States leads with advanced manufacturing infrastructure and strong clinical trial activity, supported by a robust network of hospitals, pharmaceutical companies, and research institutes. Latin American markets are emerging as cost-competitive manufacturing hubs, bolstered by favorable trade agreements.

Europe, the Middle East & Africa present a fragmented regulatory landscape, with the EU’s Medical Device Regulation providing a comprehensive framework for product approval, while Middle Eastern nations are rapidly developing health-care infrastructure to adopt bioresorbable technologies. Africa offers nascent opportunities in tissue engineering and wound care but requires investment in local manufacturing and training.

Asia-Pacific remains a critical growth frontier, driven by rising healthcare expenditure, expanding biopharma R&D, and government initiatives to promote domestic polymer production. China and India are scaling up extrusion and injection molding capabilities, while Southeast Asian nations focus on niche applications such as wound healing devices. Across all regions, localization strategies, partnerships with academic institutions, and regulatory harmonization efforts will be pivotal to capturing market share and ensuring sustainable growth.

Competitive Landscape and Notable Company Developments

The competitive landscape of bioresorbable polymers encompasses a mix of established chemical conglomerates and agile specialty firms. Multinational corporations such as Evonik Industries and Merck KGaA leverage extensive R&D budgets and global distribution channels to introduce advanced polylactic acid formulations. Koninklijke DSM and Corbion NV focus on sustainable biopolymer production, integrating renewable feedstocks into their supply chains.

Specialized innovators like 3D Biotek LLC and Galatea Surgical, Inc. pioneer scaffold manufacturing techniques and custom implant geometries, while CD Bioparticles and Poly-Med Incorporated advance drug encapsulation technologies. Mid-sized players such as Ashland Inc. and SEQENS SAS optimize polymer blends for specific therapeutic windows. In emerging markets, firms like Nomisma Healthcare Pvt. Ltd. and Vibha Ecopac Pvt Ltd. are establishing footholds through local partnerships and cost-competitive offerings.

Recent strategic collaborations further underscore the market’s dynamism: Avantium N.V. has allied with medical device OEMs to co-develop bioresorbable stents, while Futerro Group and Huizhou Foryou Medical Devices Co., Ltd. are exploring novel polyhydroxyalkanoates for regenerative medicine. Across the spectrum, the interplay of scale, specialty expertise, and strategic alliances will determine which companies lead the next wave of innovation.

Actionable Recommendations for Industry Leaders

Industry leaders can capitalize on emerging opportunities by adopting the following recommendations:
  • Expand R&D collaboration with academic and clinical partners to accelerate translation of novel polymers, particularly those with renewable feedstocks and tunable degradation profiles.
  • Diversify manufacturing footprints across tariff-advantaged regions and invest in modular extrusion, injection, and blow molding platforms to enhance supply chain resilience.
  • Prioritize regulatory intelligence and early engagement with authorities to streamline approvals under evolving global standards, such as the EU Medical Device Regulation and U.S. FDA guidelines.
  • Tailor product portfolios to end-user needs by developing formulation-specific drug delivery vehicles, scaffold architectures for targeted tissue repair, and advanced wound-healing composites.
  • Explore strategic alliances and licensing agreements to gain market access in high-growth Asia-Pacific and Latin American territories, leveraging local manufacturing and distribution networks.
By implementing these actions, organizations can strengthen their competitive positioning, accelerate time to market, and address unmet clinical needs.

Conclusion: Preparing for the Next Phase of Market Evolution

The bioresorbable polymers market stands at a critical juncture, characterized by rapid technological advancements, evolving trade policies, and intensifying competition. Companies that align innovation with strategic regional expansion, while proactively managing regulatory and tariff challenges, will emerge as market leaders. A holistic approach-integrating material science breakthroughs, agile manufacturing, and targeted partnerships-will unlock the full potential of bioresorbable technologies. As clinical adoption expands across drug delivery, medical implants, and tissue engineering, the industry will shift from niche applications to mainstream medical solutions, ultimately improving patient outcomes and delivering sustainable growth.

Market Segmentation & Coverage

This research report categorizes the Bioresorbable Polymers Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Fibers
  • Films
  • Micro-Particles
  • Nanomaterials
  • Liquid
  • Powder
  • Solid
  • Blow Molding
  • Extrusion
  • Injection Molding
  • Polyanhydrides
  • Polycaprolactone (PCL)
  • Polyglycolic Acid (PGA)
  • Polyhydroxyalkanoate (PHA)
  • Polylactic Acid (PLA)
  • Drug Delivery Systems
    • Controlled Release Formulations
    • Target-Specific Vehicles
  • Medical Implants
    • Cardiovascular Stents
    • Orthopedic Implants
  • Tissue Engineering
    • Scaffold Designs
    • Stem Cell Scaffolding
  • Wound Healing Devices
    • Adhesive Solutions
    • Bandaging Materials
  • Biotechnology Companies
  • Hospitals and Clinics
  • Pharmaceutical Companies
  • Research Institutes

This research report categorizes the Bioresorbable Polymers Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Bioresorbable Polymers Market to delves into recent significant developments and analyze trends in each of the following companies:

  • 3D Biotek LLC
  • Acuro Organics Limited
  • Advanced Polymer Materials Inc.
  • Anhui Jumei Biological Technology Co., Ltd.
  • Ashland Inc.
  • Avantium N.V.
  • BMG Incorporated
  • CD Bioparticles
  • Corbion NV
  • Evonik Industries AG
  • Foster Corporation
  • Futerro Group
  • Galatea Surgical, Inc.
  • Huizhou Foryou Medical Devices Co., Ltd.
  • Koninklijke DSM N.V.
  • MAST Biosurgery
  • Merck KGaA
  • Mitsui & Co., Ltd.
  • Nanosoft Polymers
  • Nomisma Healthcare Pvt. Ltd.
  • Otto Chemie Pvt. Ltd.
  • Poly-Med Incorporated
  • PolyNovo Limited
  • Polysciences, Inc.
  • Putnam Plastics
  • REVA Medical, LLC
  • Rivika Bio Industries Pvt. Ltd.
  • SEQENS SAS
  • Solanyl Biopolymers Inc.
  • SpecialChem S.A.
  • Stahl Holdings B.V.
  • Torise Biomaterials Co.,Ltd.
  • UBQ Materials Ltd.
  • Vibha Ecopac Pvt Ltd.
  • Zeus Industrial Products, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bioresorbable Polymers Market, by Product
8.1. Introduction
8.2. Fibers
8.3. Films
8.4. Micro-Particles
8.5. Nanomaterials
9. Bioresorbable Polymers Market, by Form
9.1. Introduction
9.2. Liquid
9.3. Powder
9.4. Solid
10. Bioresorbable Polymers Market, by Manufacturing Process
10.1. Introduction
10.2. Blow Molding
10.3. Extrusion
10.4. Injection Molding
11. Bioresorbable Polymers Market, by Material Type
11.1. Introduction
11.2. Polyanhydrides
11.3. Polycaprolactone (PCL)
11.4. Polyglycolic Acid (PGA)
11.5. Polyhydroxyalkanoate (PHA)
11.6. Polylactic Acid (PLA)
12. Bioresorbable Polymers Market, by Application
12.1. Introduction
12.2. Drug Delivery Systems
12.2.1. Controlled Release Formulations
12.2.2. Target-Specific Vehicles
12.3. Medical Implants
12.3.1. Cardiovascular Stents
12.3.2. Orthopedic Implants
12.4. Tissue Engineering
12.4.1. Scaffold Designs
12.4.2. Stem Cell Scaffolding
12.5. Wound Healing Devices
12.5.1. Adhesive Solutions
12.5.2. Bandaging Materials
13. Bioresorbable Polymers Market, by End-User
13.1. Introduction
13.2. Biotechnology Companies
13.3. Hospitals and Clinics
13.4. Pharmaceutical Companies
13.5. Research Institutes
14. Americas Bioresorbable Polymers Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Bioresorbable Polymers Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Bioresorbable Polymers Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. 3D Biotek LLC
17.3.2. Acuro Organics Limited
17.3.3. Advanced Polymer Materials Inc.
17.3.4. Anhui Jumei Biological Technology Co., Ltd.
17.3.5. Ashland Inc.
17.3.6. Avantium N.V.
17.3.7. BMG Incorporated
17.3.8. CD Bioparticles
17.3.9. Corbion NV
17.3.10. Evonik Industries AG
17.3.11. Foster Corporation
17.3.12. Futerro Group
17.3.13. Galatea Surgical, Inc.
17.3.14. Huizhou Foryou Medical Devices Co., Ltd.
17.3.15. Koninklijke DSM N.V.
17.3.16. MAST Biosurgery
17.3.17. Merck KGaA
17.3.18. Mitsui & Co., Ltd.
17.3.19. Nanosoft Polymers
17.3.20. Nomisma Healthcare Pvt. Ltd.
17.3.21. Otto Chemie Pvt. Ltd.
17.3.22. Poly-Med Incorporated
17.3.23. PolyNovo Limited
17.3.24. Polysciences, Inc.
17.3.25. Putnam Plastics
17.3.26. REVA Medical, LLC
17.3.27. Rivika Bio Industries Pvt. Ltd.
17.3.28. SEQENS SAS
17.3.29. Solanyl Biopolymers Inc.
17.3.30. SpecialChem S.A.
17.3.31. Stahl Holdings B.V.
17.3.32. Torise Biomaterials Co.,Ltd.
17.3.33. UBQ Materials Ltd.
17.3.34. Vibha Ecopac Pvt Ltd.
17.3.35. Zeus Industrial Products, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIORESORBABLE POLYMERS MARKET MULTI-CURRENCY
FIGURE 2. BIORESORBABLE POLYMERS MARKET MULTI-LANGUAGE
FIGURE 3. BIORESORBABLE POLYMERS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BIORESORBABLE POLYMERS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BIORESORBABLE POLYMERS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIORESORBABLE POLYMERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FIBERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FILMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MICRO-PARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY NANOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BLOW MOLDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYANHYDRIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYHYDROXYALKANOATE (PHA), BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYLACTIC ACID (PLA), BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CONTROLLED RELEASE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TARGET-SPECIFIC VEHICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CARDIOVASCULAR STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SCAFFOLD DESIGNS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY STEM CELL SCAFFOLDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ADHESIVE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BANDAGING MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 80. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 81. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 82. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 84. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 85. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 86. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 87. CANADA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 90. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 91. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 92. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 94. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 95. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 96. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 97. MEXICO BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES BIORESORBABLE POLYMERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 116. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 118. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 124. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 126. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 127. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 128. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 129. AUSTRALIA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 132. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 133. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 134. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 136. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 137. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 138. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 139. CHINA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 142. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 143. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 144. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 146. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 147. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 148. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 149. INDIA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 152. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 153. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 154. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 156. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 157. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 158. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 159. INDONESIA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 162. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 163. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 164. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 166. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 167. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 168. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 169. JAPAN BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 172. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 173. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 174. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 176. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 177. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 178. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 179. MALAYSIA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 182. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 183. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 184. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 186. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 187. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 188. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 189. PHILIPPINES BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 192. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 193. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 194. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 196. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 197. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 198. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 199. SINGAPORE BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 202. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 203. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 204. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 206. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 207. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 208. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 209. SOUTH KOREA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 212. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 213. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 214. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 216. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 217. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 218. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 219. TAIWAN BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 222. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 223. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 224. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 226. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 227. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 228. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 229. THAILAND BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 232. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 233. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 234. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 236. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 237. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 238. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 239. VIETNAM BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 251. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 252. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 253. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 254. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 255. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 257. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 258. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 259. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 260. DENMARK BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 261. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 262. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 263. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 264. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 265. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 267. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 268. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 269. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 270. EGYPT BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 271. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 272. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 273. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 274. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 275. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 277. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 278. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 279. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 280. FINLAND BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 281. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 282. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 283. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 284. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 285. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 287. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 288. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 289. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 290. FRANCE BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 291. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 292. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 293. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 294. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 295. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 296. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 297. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 298. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 299. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 300. GERMANY BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 301. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 302. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 303. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 304. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 305. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 307. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 308. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 309. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 310. ISRAEL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 311. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 312. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 313. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 314. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 315. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 316. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 317. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 318. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 319. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2030 (USD MILLION)
TABLE 320. ITALY BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 321. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 322. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 323. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 324. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 325. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 326. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 327. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 328. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 329. NETHERLANDS BIORESORBABLE POLYMERS MARKET SIZE,

Companies Mentioned

  • 3D Biotek LLC
  • Acuro Organics Limited
  • Advanced Polymer Materials Inc.
  • Anhui Jumei Biological Technology Co., Ltd.
  • Ashland Inc.
  • Avantium N.V.
  • BMG Incorporated
  • CD Bioparticles
  • Corbion NV
  • Evonik Industries AG
  • Foster Corporation
  • Futerro Group
  • Galatea Surgical, Inc.
  • Huizhou Foryou Medical Devices Co., Ltd.
  • Koninklijke DSM N.V.
  • MAST Biosurgery
  • Merck KGaA
  • Mitsui & Co., Ltd.
  • Nanosoft Polymers
  • Nomisma Healthcare Pvt. Ltd.
  • Otto Chemie Pvt. Ltd.
  • Poly-Med Incorporated
  • PolyNovo Limited
  • Polysciences, Inc.
  • Putnam Plastics
  • REVA Medical, LLC
  • Rivika Bio Industries Pvt. Ltd.
  • SEQENS SAS
  • Solanyl Biopolymers Inc.
  • SpecialChem S.A.
  • Stahl Holdings B.V.
  • Torise Biomaterials Co.,Ltd.
  • UBQ Materials Ltd.
  • Vibha Ecopac Pvt Ltd.
  • Zeus Industrial Products, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Resorbable (Bioresorbable) Polymers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Resorbable (Bioresorbable) Polymers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
2025 Bioresorbable Polymers Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032 - Product Image

2025 Bioresorbable Polymers Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032

  • Report
  • 155 Pages
  • Global
From
Bioresorbable (Resorbable) Polymers - Global Strategic Business Report - Product Image

Bioresorbable (Resorbable) Polymers - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Biodegradable Bone Graft Polymers - Global Strategic Business Report - Product Image

Biodegradable Bone Graft Polymers - Global Strategic Business Report

  • Report
  • 143 Pages
  • Global
From
Shape Memory Polymer Market - Forecasts from 2024 to 2029 - Product Image

Shape Memory Polymer Market - Forecasts from 2024 to 2029

  • Report
  • 140 Pages
  • Global
From

About the Bioresorbable Polymer Market

Bioresorbable polymers are a type of plastic that can be broken down by the body's natural processes. They are used in medical applications such as drug delivery, tissue engineering, and wound healing. They are also used in the food industry for packaging and in the automotive industry for parts. Bioresorbable polymers are advantageous because they are biocompatible, biodegradable, and non-toxic. They are also cost-effective and can be tailored to meet specific needs. Some companies in the bioresorbable polymer market include BASF, Evonik, Corbion, and PolyOne. These companies produce a variety of bioresorbable polymers for medical, food, and automotive applications. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.